张蔷;高文远;满淑丽;
ZHANG Qiang1,2,GAO Wen-yuan1,MAN Shu-li1(1.School of Pharmaceutical Science and Technology,Tianjin University,Tianjin 300072,China; 2.Tianjin Medical University General Hospital Institute of Geriatrics,Tianjin 300072,China)

• 1:天津大学药物科学与技术学院
• 2:天津医科大学总医院老年病研究所

摘要(Abstract)：

黄芪药用历史悠久,古有"补药之长"之称,为历代中医最常用的中药之一。近年来,国内外学者对黄芪的化学组成、药理活性进行了较为广泛的研究。成分分析表明,黄芪以多糖、三萜、黄酮等成分为主;药理实验及临床报道表明,黄芪在免疫调节、抗肿瘤、抗病毒、糖尿病、延缓衰老等方面具有重要作用。因此,对黄芪的各个有效成分的活性总结具有临床指示性意义。该文通过文献综述,总结了黄芪不同活性成分的药理活性及作用机制,为该药临床研究提供理论依据,进而为其开发利用提供依据。
Astragali Radix,as a tonic with a long history,is one of the most common traditional Chinese medicines.Recently,chemical composition and pharmacological activities of Astragali Radix have been widely reported.Polysaccharide,triterpenes and flavonoids are regarded to its effective components.Pharmacological experiments and clinical reports show that Astragali Radix has good effects on immune-regulation,anti-tumor,anti-virus,diabetes,anti-aging and so on.Therefore,it shows a good prospect to make good use of its effective components.

关键词(KeyWords)： 黄芪;多糖;三萜;黄酮
Astragali Radix;active ingredient;pharmacological activities;polysaccharides;triterpenes

Abstract:

Keywords:

基金项目(Foundation): 天津市自然科学基金项目(10JCYBJC25800);; 天津医科大学基金资助项目(2009KY17);;

作者(Authors): 张蔷;高文远;满淑丽;
ZHANG Qiang1,2,GAO Wen-yuan1,MAN Shu-li1(1.School of Pharmaceutical Science and Technology,Tianjin University,Tianjin 300072,China; 2.Tianjin Medical University General Hospital Institute of Geriatrics,Tianjin 300072,China)

参考文献(References)：

• [1]陈艳蕊,毛欣月,金文闻,等.黄芪多糖结构及其单糖组成的气相色谱-质谱研究[J].现代生物医学进展,2011(S1):4632.
• [2]Y F Wang,X F Yang,B Cheng,et al.Protective effect of As-tragalus polysaccharides on ATP binding cassette transporter A1in THP-1 derived foam cells exposed to tumor necrosis factor-al-pha[J].Phytother Res,2010,24(3):393.
• [3]X Q Mao,F Yu,N Wang,er al.Ouyang,hypoglycemic effect ofpolysaccharide enriched extract of Astragalus membranaceus in di-et induced insulin resistant C57BL/6J mice and its potentialmechanism[J].Phytomedicine,2009,16(5):416.
• [4]X Huang,D Wang,Y Hu,et al.Effect of sulfated astragaluspolysaccharide on cellular infectivity of infectious bursal diseasevirus[J].Int J Biol Macromol,2008,42(2):166.
• [5]S Li,Y Zhang,J Zhao.Preparation and suppressive effect of As-tragalus polysaccharide in glomerulonephritis rats[J].Int Immu-nopharmacol,2007,7(1):23.
• [6]H Zhang,N Pan,S Xiong,et al.Inhibition of polyglutamine-me-diated proteotoxicity by Astragalus membranaceus polysaccharidethrough the DAF-16/FOXO transcription factor in caenorhabditiselegans[J].Biochem J,2012,441(1):417.
• [7]郇志利,黄云,毛小伟,等.黄芪及黄芪多糖在养殖上的应用[J].当代水产,2011(11):59.
• [8]B M Shao,W Xu,H Dai,et al.A study on the immune recep-tors for polysaccharides from the roots of Astragalus membrana-ceus,a Chinese medicinal herb[J].Biochem Biophys Res Com-mun,2004,320(4):1103.
• [9]林梦感,杨义芳,许海燕.黄芪多糖MAPS-5的化学结构及其体外淋巴细胞增殖活性[J].中草药,2009,40(12):1865.
• [10]K Y Lee,Y J Jeon.Macrophage activation by polysaccharide iso-lated from Astragalus membranaceus[J].Int Immunopharmacol,2005,5(7/8):1225.
• [11]L H Zhao,Z X Ma,J Zhu,et al.Characterization of polysaccha-ride from Astragalus radix as the macrophage stimulator[J].CellImmunol,2011,271(2):329.
• [12]Y Yuan,M Sun,K S Li.Astragalus mongholicus polysaccharideinhibits lipopolysaccharide-induced production of TNF-alpha andinterleukin-8[J].World J Gastroenterol,2009,15(29):3676.
• [13]J Li,Y Bao,W Lam,et al.Immunoregulatory and anti-tumoreffects of polysaccharopeptide and Astragalus polysaccharides ontumor-bearing mice[J].Immunopharmacol Immunotoxicol,2008,30(4):771.
• [14]L Guo,S P Bai,L Zhao,et al.Astragalus polysaccharide injec-tion integrated with vinorelbine and cisplatin for patients with ad-vanced non-small cell lung cancer:effects on quality of life andsurvival[J].Med Oncol,2012,29(3):1656.
• [15]X Zhou,Y Xu,G Yang,et al.Increased galectin-1 expression inmuscle of Astragalus polysaccharide-treated type 1 diabetic mice[J].J Nat Med,2011,65(3/4):500.
• [16]李如江,邱曙东,陈红霞,等.黄芪多糖对1型糖尿病小鼠胰腺β细胞总质量的影响[J].中国中药杂志,2007,32(20):2169.
• [17]R J Li,S D Qiu,H X Chen,et al.The immunotherapeuticeffects of Astragalus polysaccharide in type 1 diabetic mice[J].Biol Pharm Bull,2007,30(3):470.
• [18]Y C Juan,Y H Kuo,C C Chang,et al.Administration of a de-coction of sucrose-and polysaccharide-rich Radix Astragali(huang qi)ameliorated insulin resistance and fatty liver but af-fected beta-cell function in type 2 diabetic rats[J].Evid BasedComplement Alternat Med,2011,2011:349807.
• [19]Y Wu,J P Ou-Yang,K Wu,et al.Hypoglycemic effect of As-tragalus polysaccharide and its effect on PTP1B[J].Acta Phar-macol Sin,2005,26(3):345.
• [20]W Zhang,C Zhang,R Liu,et al.Quantitative determination ofastragaloside IV,a natural product with cardioprotective activity,in plasma,urine and other biological samples by HPLC coupledwith tandem mass spectrometry[J].J Chromatogr B,2005,822(1/2):170.
• [21]Y W Zhang,C Y Wu,J T Cheng.Merit of Astragalus polysac-charide in the improvement of early diabetic nephropathy with aneffect on mRNA expressions of NF-kappaB and IkappaB in renalcortex of streptozotoxin-induced diabetic rats[J].J Ethnopharma-col,2007,114(3):387.
• [22]X Q Mao,Y Wu,K Wu,et al.Astragalus polysaccharide re-duces hepatic endoplasmic reticulum stress and restores glucosehomeostasis in a diabetic KKAy mouse model[J].Acta Pharma-col Sin,2007,28(12):1947.
• [23]X Li,D He,L Zhang,et al.A novel antioxidant agent,astraga-losides,prevents shock wave-induced renal oxidative injury inrabbits[J].Urol Res,2006,34(4):277.
• [24]S Y Gui,W Wei,H Wang,et al.Effects and mechanisms ofcrude astragalosides fraction on liver fibrosis in rats[J].J Ethno-pharmacol,2006,103(2):154.
• [25]D Meng,X J Chen,Y Y Bian,et al.Effect of astragalosides onintracellular calcium overload in cultured cardiac myocytes of neo-natal rats[J].Am J Chin Med,2005,33(1):11.
• [26]李维祖,李卫平,尹艳艳.黄芪总苷及黄芪甲苷对糖皮质激素诱导衰老大鼠氧自由基代谢的影响[J].中国中药杂志,2007,32(23):2439.
• [27]李维祖,李卫平,尹艳艳,等.黄芪总苷及黄芪甲苷对糖皮质激素诱导老前期大鼠记忆损伤的保护作用及机制[J].中国中药杂志,2009,34(2):199.
• [28]张文,李维祖,李卫平,等.黄芪总苷防治地塞米松诱导小鼠记忆障碍和对APP及β-分泌酶mRNA表达的研究[J].中国中药杂志,2010,35(5):642.
• [29]X L Xu,H Ji,S Y Gu,et al.Modification of alterations in cardi-ac function and sarcoplasmic reticulum by astragaloside IV in my-ocardial injury in vivo[J].Eur J Pharmacol,2007,568(1/3):203
• [30]X L Xu,X J Chen,H Ji,et al.Astragaloside IV improved intra-cellular calcium handling in hypoxia-reoxygenated cardiomyocytesvia the sarcoplasmic reticulum Ca-ATPase[J].Pharmacology,2008,81(4):325.
• [31]Z P Li,Q Cao.Effects of astragaloside IV on myocardial calciumtransport and cardiac function in ischemic rats[J].Acta Pharma-col Sin,2002,23(10):898.
• [32]J Y Hu,J Han,Z G.Chu,et al.Astragaloside IV attenuates hy-poxia-induced cardiomyocyte damage in rats by upregulating su-peroxide dismutase-1 levels[J].Clin Exp Pharmacol Physiol,2009,36(4):351.
• [33]L Zhang,Q Liu,L Lu,et al.Astragaloside IV stimulates angio-genesis and increases hypoxia-inducible Factor-1{alpha}accumu-lation via phosphatidylinositol 3-kinase/Akt pathway[J].J Phar-macol Exp Ther,2011,338(2):485.
• [34]W D Zhang,H Chen,C Zhang,et al.Astragaloside IV from As-tragalus membranaceus shows cardioprotection during myocardialischemia in vivo and in vitro[J].Planta Med,2006,72(1):4.
• [35]Y Luo,Z Qin,Z Hong,X Zhang,et al.Astragaloside IV pro-tects against ischemic brain injury in a murine model of transientfocal ischemia[J].Neurosci Lett,2004,363(3):218.
• [36]M X Cheng,Z Z Chen,Y L Cai,et al.Astragaloside IV protectsagainst ischemia reperfusion in a murine model of orthotopic livertransplantation[J].Transplant Proc,2011,43(5):1456.
• [37]Y Z Qu,M Li,Y L Zhao,et al.Astragaloside IV attenuates cer-ebral ischemia-reperfusion-induced increase in permeability of theblood-brain barrier in rats[J].Eur J Pharmacol,2009,606(1/3):137.
• [38]W S Chan,S S Durairajan,J H Lu,et al.Neuroprotective effectsof astragaloside IV in 6-hydroxydopamine-treated primary nigralcell culture[J].Neurochem Int,2009,55(6):414.
• [39]Z H Zhu,H T Wan,J H Li.Chuanxiongzine-astragaloside IV de-creases IL-1beta and Caspase-3 gene expressions in rat brain dam-aged by cerebral ischemia/reperfusion:a study of real-time quan-titative PCR assay[J].Acta Physiol Sin,2011,63(3):272.
• [40]Z Zhao,W Wang,F Wang,et al.Effects of astragaloside IV onheart failure in rats[J].Chin Med,2009,4:6.
• [41]石海莲,马春来,刘燕,等.黄芪皂苷甲抑制压力过载型心肌肥厚大鼠肾素-血管紧张素的过度激活[J].中国中药杂志,2009,34(24):3242.
• [42]L H Qiu,X J Xie,B Q Zhang.Astragaloside IV improves homo-cysteine-induced acute phase endothelial dysfunction via antioxi-dation[J].Biol Pharm Bull,2010,33(4):641.
• [43]N Zhang,X H Wang,S L Mao,et al.Astragaloside IV improvesmetabolic syndrome and endothelium dysfunction in fructose-fedrats[J].Molecules,2011,16(5):3896.
• [44]C Y Cheng,C H Yao,B S Liu,et al.The role of astragaloside inregeneration of the peripheral nerve system[J].J Biomed MaterRes,2006,76(3):463.
• [45]张川,柳润辉,李慧梁,等.黄芪甲苷对大鼠心肌基因表达谱的影响[J].中国中药杂志,2008,33(2):172.
• [46]S Wang,J Li,H Huang,et al.Anti-hepatitis B virus activities ofastragaloside IV isolated from Radix Astragali[J].Biol PharmBull,2009,32(1):132.
• [47]L Shang,Z Qu,L Sun,et al.Astragaloside IV inhibits adenovi-rus replication and apoptosis in A549 cells in vitro[J].J PharmPharmacol,2011,63(5):688.
• [48]Y Zhang,H Zhu,C Huang,et al.Astragaloside IV exerts antivi-ral effects against coxsackievirus B3 by upregulating interferon-gamma[J].J Cardiovasc Pharmacol,2006,47(2):190.
• [49]P Chen,Y Xie,E Shen,et al.Astragaloside IV attenuates myo-cardial fibrosis by inhibiting TGF-beta1 signaling in coxsackievir-us B3-induced cardiomyopathy[J].Eur J Pharmacol,2011,658(2/3):168.
• [50]Z C Zhang,S J Li,Y Z Yang,et al.Effect of astragaloside oncardiomyocyte apoptosis in murine coxsackievirus B3 myocarditis[J].J Asian Nat Prod Res,2007,9(2):145.
• [51]B Jiang,Y Yang,H Jin,et al.Astragaloside IV attenuates lipol-ysis and improves insulin resistance induced by TNFalpha in 3T3-L1 adipocytes[J].Phytother Res,2008,22(11):1434.
• [52]L Lv,S Y Wu,G.F Wang,et al.Effect of astragaloside IV onhepatic glucose-regulating enzymes in diabetic mice induced by ahigh-fat diet and streptozotocin[J].Phytother Res,2010,24(2):219.
• [53]H Liu,W Wei,W Y Sun,et al.Protective effects of astragalo-side IV on porcine-serum-induced hepatic fibrosis in rats and invitro effects on hepatic stellate cells[J].J Ethnopharmacol,2009,122(3):502.
• [54]Y P Wang,X Y Li,C Q Song,et al.Effect of astragaloside IVon T,B lymphocyte proliferation and peritoneal macrophage func-tion in mice[J].Acta Pharmacol Sin,2002,23(3):263.
• [55]W J Zhang,P Hufnagl,B R Binder,et al.Antiinflammatory ac-tivity of astragaloside IV is mediated by inhibition of NF-kappaBactivation and adhesion molecule expression[J].Thromb Haemo-stasis,2003,90(5):904.
• [56]L Verotta,M Guerrini,N A El-Sebakhy,et al.Cycloartane andoleanane saponins from Egyptian Astragalus spp.as modulators oflymphocyte proliferation[J].Planta Med,2002,68(11):986.
• [57]L Verotta,M Guerrini,N A El-Sebakhy,et al.Cycloartane sapo-nins from Astragalus peregrinus as modulators of lymphocyte prolif-eration[J].Fitoterapia,2001,72(8):894.
• [58]A Nalbantsoy,T Nesil,S Erden,et al.Adjuvant effects of As-tragalus saponins macrophyllosaponin B and astragaloside VII[J].J Ethnopharmacol,2011,134(3):897.
• [59]I Ionkova,G Momekov,P Proksch.Effects of cycloartane sapo-nins from hairy roots of Astragalus membranaceus Bge.,on humantumor cell targets[J].Fitoterapia,2010,81(5):447.
• [60]M M Tin,C H Cho,K Chan,et al.Astragalus saponins inducegrowth inhibition and apoptosis in human colon cancer cells andtumor xenograft[J].Carcinogenesis,2007,28(6):1347.
• [61]K K Auyeung,C H Cho,J K Ko.A novel anticancer effect of As-tragalus saponins:transcriptional activation of NSAID-activatedgene[J].Int J Cancer,2009,125(5):1082.
• [62]I N Krasteva,R A Toshkova,S D Nikolov.Protective effect ofAstragalus corniculatus saponins against myeloid graffi tumour inhamsters[J].Phytother Res,2004,18(3):255.
• [63]E Yesilada,E.Bedir,I Calis,et al.Effects of triterpene sapo-nins from Astragalus species on in vitro cytokine release[J].JEthnopharmacol,2005,96(1/2):71.
• [64]K Motomura,Y Fujiwara,N Kiyota,et al.Astragalosides isola-ted from the root of Astragalus radix inhibit the formation of ad-vanced glycation end products[J].J Agr Food Chem,2009,57(17):7666.
• [65]梁连生,余静,宋瑞霞,等.甘肃黄芪黄酮对AngⅡ致内皮细胞凋亡的保护作用[J].中国药理学通报,2006,22(12):1505.
• [66]张冬青,汪德清,于勇.黄芪总黄酮和毛蕊异黄酮对K562细胞的抑制作用及其机制研究[J].中国中药杂志,2011,36(24):3502.